Attached files
file | filename |
---|---|
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - SCIENTIFIC INDUSTRIES INC | exhbit32.htm |
10-Q - SIFORM10Q1217 - SCIENTIFIC INDUSTRIES INC | siform10q1217-_2918upload.htm |
Exhibit 31.0
CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT
I, Helena R. Santos, certify that:
1.
I
have reviewed this Annual Report on Form 10-K of Scientific
Industries, Inc.;
2.
Based
on my knowledge, this report does not contain any untrue statement
of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the
period covered by this report;
3.
Based
on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in
this report;
4.
I
am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Securities Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:
a)
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under my supervision, to
ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to me by
others within those entities, particularly during the period in
which this report is being prepared;
b)
Designed
such internal control over financial reporting, or caused such
internal control over financial reporting to be designed under my
supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purpose in accordance with generally
accepted accounting principles;
c)
Evaluated
the effectiveness of the registrant’s disclosure controls and
procedures, and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the
end of the period covered by this report based on such evaluation;
and
d)
Disclosed
in this report any change in the registrant’s internal
control over financial reporting (that occurred during the
registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter) that has materially
affected, or is reasonable likely to materially affect, the
registrant’s internal control over financial reporting;
and
5.
I
have disclosed, based on my most recent evaluation of internal
control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s Board of
Directors (or persons performing the equivalent
functions);
a)
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial
information; and
b)
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s
internal control over financial reporting.
|
Scientific Industries, Inc.
|
||
|
|
|
|
|
|
|
|
Date: September 29, 2017
|
By:
|
/s/ Helena R. Santos
|
|
|
|
Helena R. Santos
|
|
|
|
Chief Executive Officer and
|
|
|
|
Chief Financial Officer
|
|